Scholarlink

<p>The present study aims to synthesize a multifunctional nanocomposite, ZnO/SnO<sub>2</sub>/CS comprising zinc oxide (ZnO), tin oxide (SnO<sub>2</sub>), and crab shell-derived biopolymer chitosan (CS), and evaluate its abilities in antioxidant, antidiabetic, anti-inflammatory, and cytotoxic applications. Cancer is a group of illnesses caused by the uncontrolled growth and proliferation of abnormal cells, is a leading cause of death worldwide, responsible for nearly one in six deaths. The treatment of cancer becomes more complicated when a patient has several comorbidities. There is a need to develop anti-cancer agents with multiple health benefits. The structural, optical, and morphological properties of the synthesized nanocomposite were carried out by XRD, FTIR, FESEM, EDS with mapping, HR-TEM, XPS, and PL spectroscopy. The biomedical potential of the nanocomposite was evaluated by antioxidants (DPPH and superoxide), antidiabetic (α-glucosidase), anti-inflammatory (protein denaturation), and cytotoxicity (MTT) assays. The nanocomposite ZnO/SnO<sub>2</sub>/CS revealed 93.86 % and 93.28 % inhibition of free radicals in the DPPH and superoxide radical scavenging assays, with IC<sub>50</sub> values of 107.07 ± 0.41&#xa0;µg/mL and 140.66 ± 1.32&#xa0;µg/mL, respectively. Similarly, the nanocomposite revealed better antioxidant and anti-inflammatory capability against α-glucosidase and protein denaturation assays with IC<sub>50</sub> values of 102.68 ± 0.82 and 131.32 ± 0.97&#xa0;µg/mL, respectively. The cytotoxicity assay showed an IC<sub>50</sub> value of 15.197 ± 1.960&#xa0;µg/mL for lung cancer cells (A-549) and 18.607 ± 2.641&#xa0;µg/mL for breast cancer cells (MDA-MB-231). The cell morphological analyses and EtBr fluorescence staining demonstrated the apoptosis induced cell death. The multiple health benefits of the ZnO/SnO<sub>2</sub>/CS nanocomposite make it a favourable candidate for further anticancer research.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Bio-Derived Chitosan-Based ZnO/SnO₂ Nanocomposites: Evaluation of Cytotoxic and Biomedical Potential

  • 期刊论文

  • 发表日期：

    2026年3月24日

查看全文
  • N. Ambika Devi,
  • R. Mohan,
  • T. William Raja,
  • M. Meenakshi Sundari,
  • M. Ayyanar,
  • P. Ravikumar,
  • Elumalai Perumal,
  • K. Ravichandran,
  • Michael Pillay

摘要

The present study aims to synthesize a multifunctional nanocomposite, ZnO/SnO2/CS comprising zinc oxide (ZnO), tin oxide (SnO2), and crab shell-derived biopolymer chitosan (CS), and evaluate its abilities in antioxidant, antidiabetic, anti-inflammatory, and cytotoxic applications. Cancer is a group of illnesses caused by the uncontrolled growth and proliferation of abnormal cells, is a leading cause of death worldwide, responsible for nearly one in six deaths. The treatment of cancer becomes more complicated when a patient has several comorbidities. There is a need to develop anti-cancer agents with multiple health benefits. The structural, optical, and morphological properties of the synthesized nanocomposite were carried out by XRD, FTIR, FESEM, EDS with mapping, HR-TEM, XPS, and PL spectroscopy. The biomedical potential of the nanocomposite was evaluated by antioxidants (DPPH and superoxide), antidiabetic (α-glucosidase), anti-inflammatory (protein denaturation), and cytotoxicity (MTT) assays. The nanocomposite ZnO/SnO2/CS revealed 93.86 % and 93.28 % inhibition of free radicals in the DPPH and superoxide radical scavenging assays, with IC50 values of 107.07 ± 0.41 µg/mL and 140.66 ± 1.32 µg/mL, respectively. Similarly, the nanocomposite revealed better antioxidant and anti-inflammatory capability against α-glucosidase and protein denaturation assays with IC50 values of 102.68 ± 0.82 and 131.32 ± 0.97 µg/mL, respectively. The cytotoxicity assay showed an IC50 value of 15.197 ± 1.960 µg/mL for lung cancer cells (A-549) and 18.607 ± 2.641 µg/mL for breast cancer cells (MDA-MB-231). The cell morphological analyses and EtBr fluorescence staining demonstrated the apoptosis induced cell death. The multiple health benefits of the ZnO/SnO2/CS nanocomposite make it a favourable candidate for further anticancer research.